TheSGLT-2 inhibitor dapagliflozin ehnanced the anticancer activities and exerts cardioprotective effects during exposure to ipilimumab through NLRP3 inflammasome and pro-fibrotic cytokines
Authors: N Maurea, V Quagliariello, A Bonelli, A Paccone, G Conforti, A Caronna, S Buccolo, M Iovine, F Cerrone, G Botti